Feedback / Questions
PTX-100 - Prescient Therap
https://www.proactiveinvestors.com/companies/news/1071864/prescient-therapeutics-doses-first-patient-in-phase-2a-study-of-ptx-100-for-rare-blood-cancer-1071864.html
May 26, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next